ANTAGONISTS OF IL-6 TO PREVENT OR TREAT CACHEXIA, WEAKNESS, FATIGUE, AND/OR FEVER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20190270805A1
SERIAL NO

16191514

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to therapeutic methods using antibodies and fragments thereof having binding specificity for IL-6 to prevent or treat cachexia, fever, weakness and/or fatigue in a patient in need thereof. In preferred embodiments these patients will comprise those exhibiting (or at risk of developing) an elevated serum C-reactive protein level. In another preferred embodiment, the patient's survivability or quality of life will preferably be improved.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
H LUNDBECK A/SVALBY

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
LATHAM, JOHN SEATTLE, US 106 3193
LITTON, MARK SEATTLE, US 24 604
SCHATZMAN, RANDALL C REDMOND, US 16 205
SMITH, JEFFREY TL BELLEVUE, US 132 1527

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation